Cadence Bank Gsk PLC Transaction History

Cadence Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$32.47 - $48.83 $183,033 - $275,254	-5,637 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$42.0 - $48.25 $4,746 - $5,452	113 Added 2.05%	5,637 $265,000
Q3 2019 Nov 06, 2019	BUY	$40.46 - $43.52 $223,501 - $240,404	5,524 New	5,524 $236,000
Q2 2019 Jul 30, 2019	SELL	$39.4 - $42.7 $219,930 - $238,351	-5,582 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$38.57 - $42.69 $63,177 - $69,926	-1,638 Reduced 22.69%	5,582 $233,000
Q4 2018 Feb 07, 2019	SELL	$37.8 - $42.69 $38,178 - $43,116	-1,010 Reduced 12.27%	7,220 $276,000
Q3 2018 Oct 25, 2018	SELL	$39.75 - $42.69 $34,503 - $37,054	-868 Reduced 9.54%	8,230 $331,000
Q2 2018 Aug 09, 2018	BUY	$39.61 - $42.76 $38,263 - $41,306	966 Added 11.88%	9,098 $367,000
Q1 2018 May 03, 2018	SELL	$36.18 - $40.15 $36,180 - $40,150	-1,000 Reduced 10.95%	8,132 $318,000
Q4 2017 Feb 12, 2018	BUY	$35.34 - $41.9 $322,724 - $382,630	9,132	9,132 $0

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

Stay updated on Cadence Bank with notifications on news.